Related references
Note: Only part of the references are listed.Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Elijah J. Mun et al.
CLINICAL CANCER RESEARCH (2018)
IMST-26. TUMOR TREATING FIELDS EXPOSURE OF TUMOR CELLS INDUCE ACTIVATION PHENOTYPE IN IMMUNE CELLS
Talia Holtzman
NEURO-ONCOLOGY (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields
Edwin Chang et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Charlotte Kelly et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Skin toxicities associated with tumor treating fields: case based review
Rimas V. Lukas et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Jay-Jiguang Zhu et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
OS07.9 Standard of care temozolomide chemotherapy ± tumor treating fields (TTFields) in newly diagnosed glioblastoma. Final results of the phase III EF-14 clinical trial
R. Stupp et al.
NEURO-ONCOLOGY (2017)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study
Anders Rosendal Korshoej et al.
PLOS ONE (2017)
Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines
Narasimha Kumar Karanam et al.
CELL DEATH & DISEASE (2017)
Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study
Ping Zhu et al.
ONCOTARGET (2017)
Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma
Edwin Lok et al.
CANCER MEDICINE (2017)
Tumor treating fields: a novel treatment modality and its use in brain tumors
Andreas F. Hottinger et al.
NEURO-ONCOLOGY (2016)
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
F. Bernard-Arnoux et al.
NEURO-ONCOLOGY (2016)
Tumor treating fields-effective, but at what cost?
Isabella Zhang et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
George Ansstas et al.
CASE REPORTS IN NEUROLOGY (2016)
Tumor treating fields: a new standard treatment for glioblastoma?
Sophie Taillibert et al.
CURRENT OPINION IN NEUROLOGY (2015)
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
Eric T. Wong et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2015)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
Moshe Giladi et al.
SCIENTIFIC REPORTS (2015)
Efficacy of Surgery and Further Treatment of Progressive Glioblastoma
Christoph Michael Woernle et al.
WORLD NEUROSURGERY (2015)
Bevacizumab for glioblastoma
Yoshitaka Narita
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
The epidemiology of glioma in adults: a state of the science review
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields
Moshe Giladi et al.
PANCREATOLOGY (2014)
Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma
Mario E. Lacouture et al.
SEMINARS IN ONCOLOGY (2014)
Alternating Electric Fields (Tumor-Treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-Small Cell Lung Cancer Both In Vitro and In Vivo
Moshe Giladi et al.
SEMINARS IN ONCOLOGY (2014)
Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)
Maciej M. Mrugala et al.
SEMINARS IN ONCOLOGY (2014)
Standards of care and novel approaches in the management of glioblastoma multiforme
Andreas F. Hottinger et al.
CHINESE JOURNAL OF CANCER (2014)
Vaccine strategies for glioblastoma: progress and future directions
Christopher Jackson et al.
IMMUNOTHERAPY (2013)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Does Extent of Resection of a Glioblastoma Matter?
Michael A. Vogelbaum
NEUROSURGERY (2012)
Assessment of Exposure to Intermediate Frequency Electric Fields and Contact Currents From a Plasma Ball
Tommi Alanko et al.
BIOELECTROMAGNETICS (2011)
TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
Rosa S. Schneiderman et al.
BMC CANCER (2010)
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
John K. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs
Eilon D. Kirson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Management of glioblastoma
Tomokazu Aoki et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
Eilon D. Kirson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Theoretical modeling for radiofrequency ablation: state-of-the-art and challenges for the future
Enrique J. Berjano
BIOMEDICAL ENGINEERING ONLINE (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
Diagnostic properties of nerve conduction tests in population-based carpal tunnel syndrome
I Atroshi et al.
BMC MUSCULOSKELETAL DISORDERS (2003)
Share Paper
